Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL) Share Price

Price 0.14p on 02-09-2026 at 16:30:01
Change -0.005p -3.45%
Buy 0.15p
Sell 0.13p
Last Trade: Sell 600,000.00 at 0.1315p
Day's Volume: 2,786,069
Last Close: 0.14p
Open: 0.145p
ISIN: GB00BLH13C52
Day's Range 0.14p - 0.145p
52wk Range: 0.135p - 0.75p
Market Capitalisation: £1.85m
VWAP: 0.136779p
Shares in Issue: 1.32b

ValiRx (VAL) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 600,000 0.1315p Ordinary
14:38:09 - 02-Sep-26
Sell* 13,000 0.1315p Ordinary
14:18:09 - 02-Sep-26
Sell* 250,000 0.1376p Ordinary
13:41:57 - 02-Sep-26
Buy* 1,333 0.15p Ordinary
13:40:57 - 02-Sep-26
Sell* 79,708 0.1376p Ordinary
13:19:53 - 02-Sep-26
Buy* 41,410 0.1488p Ordinary
12:44:34 - 02-Sep-26
Sell* 335,058 0.13p Ordinary
12:01:00 - 02-Sep-26
Sell* 483,495 0.14p Ordinary
11:39:38 - 02-Sep-26
Sell* 911,708 0.14p Ordinary
10:58:40 - 02-Sep-26
Sell* 17,000 0.14p Ordinary
09:59:09 - 02-Sep-26
See more ValiRx trades

ValiRx (VAL) Share Price History

Time period:
to
Date Open High Low Close Volume
1st Sep 2026 (Tue) 0.155 0.155 0.145 0.145 16,976,045
31st Aug 2026 (Mon) 0.155 0.155 0.155 0.155 0
28th Aug 2026 (Fri) 0.155 0.155 0.155 0.155 1,623,658
27th Aug 2026 (Thu) 0.155 0.155 0.155 0.155 729,861
26th Aug 2026 (Wed) 0.155 0.155 0.155 0.155 14,692
25th Aug 2026 (Tue) 0.155 0.155 0.155 0.155 183,400
24th Aug 2026 (Mon) 0.155 0.155 0.155 0.155 251,861
21st Aug 2026 (Fri) 0.16 0.16 0.155 0.155 1,624,822
20th Aug 2026 (Thu) 0.16 0.16 0.16 0.16 149,147
19th Aug 2026 (Wed) 0.16 0.16 0.16 0.16 145,934
18th Aug 2026 (Tue) 0.16 0.16 0.16 0.16 84,632
17th Aug 2026 (Mon) 0.16 0.16 0.16 0.16 3,467,012
14th Aug 2026 (Fri) 0.16 0.16 0.16 0.16 2,156,869
13th Aug 2026 (Thu) 0.16 0.16 0.16 0.16 1,507,285
12th Aug 2026 (Wed) 0.16 0.16 0.16 0.16 3,690,412
11th Aug 2026 (Tue) 0.16 0.16 0.16 0.16 2,022,290
10th Aug 2026 (Mon) 0.16 0.16 0.16 0.16 19,753,164
7th Aug 2026 (Fri) 0.16 0.16 0.16 0.16 1,020,672
6th Aug 2026 (Thu) 0.165 0.17 0.16 0.16 19,786,727
5th Aug 2026 (Wed) 0.15 0.165 0.15 0.165 24,360,519
4th Aug 2026 (Tue) 0.15 0.15 0.15 0.15 111,780,863
3rd Aug 2026 (Mon) 0.15 0.15 0.15 0.15 1,502,309
See more ValiRx price history

ValiRx (VAL) Regulatory News

Date Source Headline
10th Aug 2026 7:00 am RNS Cytolytix Patent Update
17th Jul 2026 12:25 pm RNS Result of AGM, Warrants & Directorate Change
22nd Jun 2026 7:00 am RNS Conclusion of Evaluation with University of Dundee
22nd Jun 2026 7:00 am RNS Final Results & Notice of AGM
2nd Jun 2026 7:00 am RNS Conclusion of Evaluation with Stingray
1st Jun 2026 7:00 am RNS ValiRx Exercises Option on Evaluation Asset
27th May 2026 7:00 am RNS Cytolytix Patent Granted
21st May 2026 7:00 am RNS Result of Oversubscribed WRAP Retail Offer
18th May 2026 7:00 am RNS WRAP Retail Offer for up to £150,000
15th May 2026 7:00 am RNS Fundraising of up to £1,155,000
See more ValiRx regulatory news

ValiRx (VAL) Share News

ValiRx subsidiary Cytolytix nears "significant" European patent win

10th Aug 2026 11:10

(Alliance News) - ValiRx PLC on Monday announced that the European Patent Office intends to grant a patent for "a key part" of majority-owned subsidiary Cytolytix Ltd's intellectual property portfolio. Read More

UK shareholder meetings calendar - next 7 days

10th Jul 2026 13:43

Read More

TRADING UPDATES: Maintel fundraising completes; ValiRx ends deal

22nd Jun 2026 14:22

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent

27th May 2026 20:36

ValiRx PLC - London-based life science company - Majority-owned subsidiary Cytolytix Ltd has its European patent "Nanoparticle for Anti-Cancer Peptides and Uses Thereof" granted. Notes the patent forms a "key part" of Cytolytix's intellectual property portfolio. Says the grant of the patent boosts Cytolytix's IP position, and affirms investment in the platform developed over the last few years. Adds that it also strengthens the firm's ability to attract external investment and expands licensing and partnership opportunities. Read More

TRADING UPDATES: IAG launches new buyback; Forgent settles legal case

15th May 2026 18:23

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

See more ValiRx news
FTSE 100 Latest
Value10,756.45
Change-32.83

Login to your account

Forgot Password?

Not Registered